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Various amino acid and pcptidc thioestcrs were tested as substrates for human protcinasc 3and the best substrate is Boc-Ala-Ala.NvnSDzl with 
a k,,lK, value oI’ 1.0 x IOb M-r .s-‘, Boc-Ala-Ala-AA-SBzl (AA = Val, Ala, or Met) arc also good substr~tcs with lr,,lK,,, vahcs of (14) x lo5 
ML1 4 d. Substituted isocoumarins arc potent inhibitors of proteinasc 3and the best inhibitors are 7-amino-4-chloro-3-(2-bron~octhoxy)isocoumurin 
and 3.4.dichloroisocoumarin (DCI) with k&I] values of 4700 and 2600 M-‘. s-l, rcspcctivcly. Substituted isocoumarins, pcptide phosphonatcs 
and chloromethyl ketones inhibited proteinasc 3less potently than human ncutrophil elastasc (HNE) by l-2 orders of magnitude. 
Pcptide chloromethyl ketone; Peptide phosphonatc; Protcinase 3; Substituted isocoumarin; Peptidc thiocster 
1. INTRODUCTION 
Protcinase 3 is a serine protease in the azurophil 
granules of polymorphonuclear leukocytes (PMN) and 
is distinct from human neutrophil elastase (HNE) and 
cathepsin G [l]. Recently, proteinase 3has been cloned 
[3] and found to be identical to the antimicrobial protein 
p29b/AGP7 13-51 and to myeloblastin, a serine protease 
derived from HL-60 leukemia cells [6,7]. Proteinase 3 is 
at least as prominent in neutrophil azurophilic granules 
as HNE [2]. The active sites of both enzymes are very 
similar [S]. Proteinase 3 degrades elastin [8], induces 
emphysema when administered to hamsters by intra- 
trachea1 instillation [l] and serves as an antigen re- 
cognized by Wegener’s Granulomatosis autoantibodies 
[8-l I]. Proteinase 3 has also been found to degrade a 
variety of other matrix proteins [12]. We report here the 
reactivity of proteinase 3 with various peptide thioester 
substrates tofurther elucidate the substrate reactivity of 
proteinase 3, and the development of inhibitors which 
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ADbrruiariorw Abu, a-aminobutanoic acid; Boc, r-butyloxycarbonyl; 
3-BrEtOIC, 3-(2-bromocthoxy)isocoumarin: DCI, 3,rl-dichloroiso; 
coumarin; DFP, diisopropyl Ruorophosphate; 3-EtOIC, 3-ethoxyiso- 
coumarin; HEPES, 4-(2.hydroxyethyl).I-pipcrazinccthane sulfonic 
acid: HNE. human neutrophil elastase; MeO. mcthoxy; Nva, Nor- 
vnline: PIPES, pi~razinc-N,lv-bis(2-ethancsulfonic acid); PMSF, 
phcnylmcthancsulfonyl fluoride; 3-PrDIC. 3-propoxyisocoumarin: 
(INA, p-nitroanilide; PPE, porcine pancreatic lastasc; ONp, p 
nitrophcnylcstcr; SBzl, thiobunzyl cstcr. 
may be useful for elucidating the function of proteinase 
3 in vitro and in vivo. 
2. EXPERIMENTAL 
Percoll was obtained from Pharmacia Fine Chemicals, Uppsala. 
Sweden. Triton X-100 was purchased from Sigma Chemical Co., St. 
Louis, MO, Adcnosine triphosphatc (ATP) was obtained from Boch- 
ringer, Mannheim, Germany. ‘%Va was obtained from the Ra- 
diochcmical Ccntre, Amersham, UK. Matrcx Gel orange A was pur- 
chased from Amicon Div., Danvers, MA. Bio-Rex 70 was obtained 
from Bio-Rad Laboratories, Richmond, CA. XARS film was pur- 
chased from Eastman Kodak Co., Rochester, NY. Purified human 
neutrophil clastase (HNE) was obtained from E&tin Products, Pa- 
cific, MO and from the research laboratory of Dr. James Travis, 
Univcrsitv of Georaia. EDTA was ourchased from Aldrich Chcmic. 
Brussels, &urn. ghccp anti-scrumbgninst cathcpsin G was obtained 
from ICN Biochcmicals, Lisle. IL. HEPES was obtained from 
Research Organ& Inc., Clcvcland. OH. 4,4’-Dithiodipyridinc was 
purchased from Aldrich Chemical Co., Milwaukee. WI. All the pp- 
tide thioestcrs were prepared as previously described [13.14]. Sub- 
stituted isocoumarins [15-l 7j, pcptidc phosphonatcz [IS], and pptidc 
chloromethyl ketones [13] were prepared previously. 
2.1. ~rcpnrurion ofprorehuse 3 
Blood from healthy donors was anticoagulated with trisodium 
citrate. Mononuclear cells and platclcts were removed by centrifuB- 
tion over isotonic Percoll with a specific gravity or 1.076 dml (I $00 
x g, 20 min. 2OOC). Erythrocytes were subsequently l sed with NH,CI 
(155 mM). KHCO, (IO mM), EDTA (IOpM) at 4% Thereafter, the 
neutrophils were washed twice with PBS/O.I% (v/v) BSA and finaliy 
resuspended in medium that consisted of 100 mM KCI, 3 mM NaCI, 
I mM ATP, 3.5 mM MSQ, IO mM PIPES. pH 7.3. More than 95% 
of the cells were ncutrophils. 
PuriALd ncutrophils, 75 x 10’ in 300 ml of medium were nitrogen 
cavitated [20]. Nuclei and unbroken cells were pelleted by ccntrifuSa- 
lion at 500 x g for 10 min at 4%. The supcrnatant was collected and 
centrifuged for 30 min at 35,000 xg at 4OC. The pellet containing the 
mixed granules fractions was resuspended in 0.08 M citrate phosphnte 
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buffer pH 3.010.18 (v/v) Triton X-100 and sonicdled at 45 kHz for 
three periods of IO s each. Thereafter, soluble and insoluble materials 
were separated by centrifugalion al 220.000 x g for I h at 4°C and the 
supernalant was stored at -70°C 
Proteinase 3was purified from crude granule xtract by dye-ligand 
aflinity chromatography over Matrex Gel orange A followed by ion- 
exchange chromatography over Bio-Rex 70. as described previously 
[I]. Prorcinase 3was detected by hydrolysis of a-naphthyl acetate and 
by ELISA using a MAb 12.8 against proteinase 3. The fractions 
containing proteinasc 3 were pooled and concentrated by ultrafiltra- 
lion using an Amicon unit (filtration cut off 10,000 Da) and dialyzed 
against PBS. Contamination with HNE and cathepsin G in the 
protcinasc 3preparation was excluded by ELISA’s [9]. using MAb NP 
57 (anti-NE) [2l] and sheep anti-serum against cathepsin G. Purity 
was further proven by the absence of contaminants in SDS-PAGE 
an;dysis with subsequent silver staining and autoradiography after 
radiolabeling (Fig. 1). Protein concentration was measured by the 
Bradford technique, using a BSA standard. A total of I.5 mg of 
proteinasc 3was puritied from approximately 150 mg of crude granule 
extract. Aliquots of 500 yg/ml were stored at -70°C. 
The enzymatic hydrolysis of peptidc thioester substrates catalyzed 
by human protcinase 3 was measured in0.1 M HEPES, 0.S M NaCI, 
pH 7.5 buffer containing 9% Mc,SO and at 25°C in the presence of 
44’.dithiodipyridinc [??I. All stock solutions of substrate were 
prcparcd in Mr,SO and stored at -20°C. The initial rates were 
measured at 324 nm &., = 19800 Me’ ‘cm-‘) using a Beckman 35 
spcctrophotometer when a IO-25 ,uI of an enzyme stock solution was 
Mr (x10-‘) Mr (x16’) 
97 - 
66 - 
42 - 
31 - 
- 14 
silver stain autoradlogram 
Fig. I. SDS-PAGE analysis of proteinasc 3 and HNE. Purified 
proleins (200 ng per lane) were applied on a lo- 15% gradient gel under 
non-reducing conditions and sraincd with silver after srptiraiiun. 12!i- 
labeled proteins (IO ng pr lane) were applied on a 12% gel under 
non-reducing conditions and visualized by autoradiography after 
separation. Protcinase 3 appeared to be pure and exhibited an clec- 
lrophorctic mobility dill’crent from HNE. 
added to a cuvctte containing 2.0 ml of buffer, ISOyl of4,4’-dithiodi- 
pyridinc (5 mM) and 25~1 of substrate. The same volume ofsubstrate 
and 4.4’.dithiodipyridine was added to the rcfcrcncc ell in order to 
compensate for the background hydrolysis rate of the substrates. Ini- 
tial rates were measured induplicate for each substrate concentration 
and wcrc avcrugcd in each cast. The kin&c constants k,,,, K,,, and 
k,,,lh:, were obtained from Lineweavcr-Burke plots which had 
correlation coefficicnis greater than 0.99. For Z-Ala-SD& the plot 
went through the origin and only k,,,IK,,, could be determined. 
An aliquot of inhibitor (25 ,ul) in Me,SO was added to 0.25 ml of 
a buffered enzyme solution (0. I3 PM) containing ulbumin (IO-25 ~1 
of 0.1 dml) to initiate the inactivation. Aliquots (SO ~1) were 
withdrawn at various intervals and the residual enzymatic activity was 
measured as described above using Sue-Ala-Ala-Nva-SBrl(88pM) as 
the substrate. The inhibitor cmlcentrations arc shown in Table II. 
Pseudo first-order inactivation rate constants (k& were obtained 
from plots of In IJ,/Y,> vs. time, and the correlation coefficients were 
grealer than 0.98. 
3. RESULTS AND DlSCUSSION 
3.1. Substrate kinetics 
The substrate activity of proteinase 3 has been stud- 
ied previously with oxidized insulin chains, and chro- 
mogenic and Ruorogenic substrates [12]. The cleavage 
of insulin chains by proteinase 3 suggests that this en- 
zyme preferentially attacks peptide bonds having small 
aliphatic amino acids such as Ala, Val, Leu and Ser at 
the PI and PI’ sites. The hydrolysis of synthetic peptides 
also indicates proteinase 3 prefers small aliphatic 
residues at the P, site and Pro at the P;? site. Proteinase 
3 did not hydrolyze HNE substrates such as Suc-Ala- 
Ala-Ala-pNA, and Sue-Ala-Ala-Val-pNA, but hy- 
drolyzed Boc-Val-ONp, Boc-Ala-ONp, MeO-Suc-Ala- 
Ala-Pro-Val-pNA, and MeO-Suc-Ala-Ile-Pro-Met- 
pNA. We have tested amino acid and peptide thioesters 
including Boc-Ala-Ala-AA-!%1 (AA = Ala, Abu, Gly, 
Arg, Asp, Asn, Met, Met(O), Pro, N\ja, Val, Ile, Leu, 
Nle, Phe, and Scr) as substrates of proteinase 3. The 
best substrates are tripeptide thioesters with Nva in the 
PI site. Z-Ala-SBzl, Boc-Ala-Ala-Ala-SBzl, Suc-Ala- 
Ala-Met-SBzl, Boc-Ala-Ala-Met-SBzl, Boc-Ala-Ala- 
Abu-SBzl, Boc-Ala-Ala-Val-SBzl, and MeO-Suc-Ala- 
Ala-Pro-Val-SBzl are also good substrates. All other 
thioesters how little activity. The kinetic constants k,,,, 
Km and k,,/K,,, of several better substrates for 
proteinase 3and HNE are shown in Table I. The kinetic 
constants of these thioester substrates for HNE have 
been reported previously [13] and are shown here for 
comparison with proteinase 3. The best substrate is 
Boc-Ala-Ala-Nva-SBzl with k,,lK, value of 1.0 x 10” 
M-l *s-I which is ca. g-fold lower than the value of 
HNE, Sue-Ala-Ala-Nva-SBzl is the only substrate 
which has a higher k,,/K,.,, value for proteinase 3 than 
for HNE. Substitution of Boc with Sue in Boc-&u-Ala- 
Met-SBzl and Boc-Ala-Ala-Nva-SBzl slightly reduced 
the k,,,lK,,, values for proteinase 3 by l.S- to 2.I-fold, 
however this substitution resulted in a 50-fold reduction 
120 
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Table I 3.2. Inhibitor kittetics 
Kinetic constants for hydrolysis or thiocster substrates by protcinasc 
3 and human lcukocytc lastasc (HNE) 
The esterolytic aitivity of protcinase 3was inhibited 
by PMSF and DFP [l]. Protcinasc 3 was not inhibited 
by the PPE inhibitor MeO-Suc-Ala-Ala-Pro-Ala- 
CHaCI, however the HNE inhibitor MeO-Suc-Ala-Ala- 
Pro-Val-CH,CI showed weak inhibition toward this en- 
zyme with kabJII] of 10 M-‘as-’ [12]. Elafin, a human 
skin inhibitor of HNE was found to be a potent inhibi- 
tor of proteinase 3with I&, of 9.5 nM [24]. A series of 
succinimidyl sulfonate derivatives have been reported to 
be potent irreversible inhibitors of protcinase 3, al- 
though their inhibition meche.nism is not yet known 
[25]. We tested substituted isocoumarins, peptide phos- 
phonates (structures shown in Fig. 2), and peptide chlo- 
romethyl ketones as inhibitors of proteinase 3 and 
HNE, and the inhibition constants are shown in Table 
II. 3,4-Dichloroisocoumarin, a general serine protease 
inhibitor, inhibited proteinase 3 quite potently with a 
k,,,l[l] of 2,600 M-’ .s-‘, which is ca. 3.5~fold ower than 
the value for HNE. The inhibitory potency of 3-alkoxy- 
7-amino-4-chloroisocoumarins toward proteinase 3 
depends on the nature of the alkoxy group. A 3-bro- 
moethoxy isocoumarin inhibited proteinase 3 ca. 6- to 
S-fold better than the corresponding 3-ethoxy and 3- 
propoxy derivatives. This trend is also observed with 
HNE. This may indicate that 3-bromoethoxyisocou- 
marin binds to the enzyme differently from 3-cthoxy 
and 3-propoxyisocoumarins. The X-ray crystal struc- 
ture of PEE and 7-amino-3-bromoethoxy-4-chloroiso- 
coumarin has been solved recently [ 171. The bro- 
moethoxy group H-bonds with Gin-192 and goes 
toward the SJ subsite instead of binding to the S, subsite 
as is likely for the other alkoxyisocoumarins. Although 
the 7-acetylamino and 7-phenylcarbamoylamino is - 
coumarin derivatives inhibited proteinase 3 more 
potently than 7-amino&chloro-3-propoxyisocoumarin 
by 3-fold, all the 7-substituted-3-bromocthoxy4chlo- 
roisocoumarins with bulky aromatic groups inhibited 
proteinase 3 less potently than the parent 7-amino com- 
pound. Substitution with bulky groups at the 7-position 
Substrates HNE” Protcinasc 3
5oc-Ala-Ala-Ala-SBzl 
Boc-Ala-Ala-Val-S5zl 
Boc-Ala-Ala-NW-S5zI 
SW-Ala-Ala-NW-SBzI 
Boc-Ala-Ala-Met-SBzl 
Sue-Ala-Ala-Met-SBzI 
Boc-Ala-Ala-lie-SBrl 
Z-Ala-SBzl 
G3 
81 
0,73 
9,o 
3.0 
3.0 
20 63.3 
2.2 63 
9.2 I.0 
II0 
590 
0.18 
52 12.2 
96 61 
0.86 0.2 
5.4 I.9 
I.4 31 
3.9 0.06 
IO.1 
I06 
0.095 
IO.4 
28 
0.38 
89.7 
I92 
0.47 
19.0 
I48 
0.13 
0.1 I
“Kinnic constants wcrc measured in 0.1 M HEPES. OS M NaCI. pH 
7.5 bull-cr. 9% Mc,SO und BL 25°C. The units fork,,,. K, and k,,IK, 
were 5-l. PM. and IOh M-‘.s-‘. 
h Data obthed from rcfercncc [131. 
in the k,,,lK,,, values for HNE. This indicates that Pd site 
of proteinase 3 is more polar than that of HNE. Boc- 
Ala-Ala-lie-SBzl had a 65-fold lower k,,,lK,, value for 
proteinase 3 than for HNE and tripeptide thioesters 
which contain Leu or Nle at P, site were poor substrates 
of proteinase 3. The partial primary structure of 
proteinase 3 has been determined [12] and comparison 
of active site region of proteinasc 3with HNE indicates 
that a strong homology exists between these two en- 
zymes. However, there are differences in several 
residues in the primary binding pocket S,. For example, 
Val-190 and Ala-21 3 of HNE which are located at the 
bottom of S, subsite [23] are replaced by Ile and Asp in 
proteinase 3 [12], and these changes may explain the 
differences in the enzymatic reactivities of proteinase 3
and HNB. Our studies 3.. . . . . _ ._. n *%JPs*~ substrates indicate 
that proteinase 3prefers smaller aliphatic residues uch 
as Ala, Val, and Nva at the P, site, while HNE can 
tolerate larger side chains such as Ilc, Leu, or Nle [ 133. 
‘; OPh 
MeO-Sue-Ala-Ala-Pro -N 
ly 
P’ 
‘OPh 
Fig. 2. Structures of substituted isocoumarins (top) and a pcptidc 
phosphonate. 3 4-Dichloroisocoumarin. X = H. Y = Cl; 7-amino-3- 
(2.bromocthoxy)+chloroisocoumorin. X = NH:. Y = WH$H,Br; 
4-chloro-7-phcnylcnrbamoylamino-3-propoxyis~oumarin~ X =
PhNHCONH, Y = OCHCH&H,. A pcptidc phosphonate MC@Suc- 
Ala-Aln-Pro-ValP(OPh)z isshown L+I the bottom ol’ the figurr. 
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Inhibition constants of protcinosc 3and HNE by substituted isocoumarins, peptide phosphonatcs and pcptide chloromethyl ketones” 
Inhibitors Proleinase 3 HNE 
3,Cdichloroisocoumnrin 
7-NH+Cl-3-EtOIC 
7-NH&Cl-3.PrOIC 
7.NH24.Cl-3.BrEtOlC 
~-CH~CONH-~-CI-~-PKJ~C 
7.PhNHCONH-rl-Cl-3-PrOIC 
7-S-(Naphthyl)(CH,)CHNHCONH-4-Cl-3-BrEtOIC 
7.A-(Naphthyl)(CH,)CHNHCONH~-Cl-3-BrEtOlC 
7.S-PhNHCOOCH(CH,)CONH-4.Cl-3.BrEtOIC 
MeO-Sue-Ala-Ala-Ala-Nva”(OPh), 
McO-Suc-Ala-Ala-Ala-Val”(OPh)z 
McO-Suc-Alu-Ala-Pro-Nva”(OPh)J 
MeO-Suc-Ala-Ala-Pro-Val’(OPh)z 
f30c-Val-Pro-Val”(OPh)z 
MeO-Sue-Ala-Ala-Pro-Val-CH2Cl 
Boc-Ala-Ala-Pro-Val-CH$l 
Z-Gly-Leu-Ala-CH,Cl 
AC.Ala-Ala-Ala-CH>Cl 
Ac-Alu-Ala-Pro-Ala-CH$l 
[II 
CuM) 
3.6 
40.7 
38 
7.3 
7.7 
7.7 
6.8 
6.2 
7.4 
427 
426 
427 
78 
323 
400 
416 
400 
395 
400 
&,JU (M-1 .gI) 
2,600 
S60 
740 
4,700 
2,200 
1,700 
2,100 
310 
1,500 
330 
2,000 
300 
3.3 
30 
21 
150 
46 
5.9 
I.4 
l4w” 
11%” 
6%’ 
[II 
CuM) 
I,1 
4 
2.6 
0.07 
I.0 
I.2 
0.44 
0.64 
0.8 
5 
95 
4.9 
4.5 
k&W (M-1 as-I) 
8,900b 
9,400c 
54,000 
200,000 
> 190,000 
140,000 
310,000 
I70,000 
I40,000 
I .500* 
380d 
7,100” 
27,000” 
1,600 
20r 
2.8’ 
44’ 
” Inhibition constants were measured in0.1 M HEPES, 05 M N&I, pH 7.5 buffer, 9% Me$O. 0.3 mg of albumin and at 25°C. Sue-Ala-Ala-Nva- 
SBzl (88 PM) was used as the substrate. 
b Data obtained from reference [ 151. 
c Data obtained from reference [ 161. 
II Data obtained from reference [IS]. 
c Percentage of inhibition was obtained after IO min of incubation. 
r Data obtained from reference [27], 
of 7.amino-4-chloro-3-propoxyisocoumarin generally 
improves the inhibitory potency toward HNE by 3- to 
4-fold, whereas the same substitution in 7-amino-3-bro- 
moethoxy-4-chloroisocoumarin did ot change the inhi- 
bitory potency significantly. These 7-acylamino groups 
are directed toward the S’ subsites [26] which indicates 
that proteinase 3 and HNE must have significant differ- 
ence in this region of the active site. It has been shown 
that Phe-41 which is part of the S,’ and S3’ subsites in 
HNE remains unchanged in proteinase 3 [12,23]. Mow- 
ever, in this region there are two insertions in proteinase 
3 when compared with HNE, a two amino acid inser- 
tion between Gly-38 and Gly-39, and a single amino 
acid insertion between Gly-39 and His-40. These inser- 
tions may account for the reactivity differences between 
proteinase 3and HNE toward acylaminoisocoumarins. 
The inhibition reaction of 7-substituted-3-bro- 
moethoxy&chloro-isocoumarin towards proteinase 3 
was biphasic and the rate constants were based on the 
40-50% inhibition observed uring the first l-2 min 
incubation. 
Peptide phosphonates are good inhibitors of HNE 
[18], but did not inhibit proteinase 3very well. The best 
inhibitor is MeO-Sue-Ala-Ala-Pro-ValP(OPh), (,&/[I] 
122 
= 27,000 M-l *S-I) which inhibits proteinase 3 ca. SO- 
fold less potently than HNE. The best HNE inhibitor 
Boc-Val-Pro-Val”(OPh), inhibits proteinase 3 with kobsl 
[I] of 50 M-l as-‘. As previously described, all the pep- 
tide chloromethyl ketones which we tested also in- 
hibited proteinase 3 poorly. Roe et al. [12] found no 
inhibition of proteinase 3 by MeO-Suc-Ala-Ala-Pro- 
Ala-CH,Cl. 
In summary, we have found that peptide thioesters 
are good substrates of proteinase 3and substituted iso- 
coumarins inhibit this enzyme quite potently. Compari- 
son of the activity of proteinase 3 and HNE indicates 
that there are significant differences in the extended 
substrate binding sites (S, subsite is more polar, S, and 
S’ subsites are more restrictive in proteinas’e 3) and the 
catalytic residues (proteinase 3 has lower reactivity 
toward most substrates and inhibitors). Thioester sub- 
strates and isocoumarin inhibitors should be useful for 
future studies on the functional role of proteinase 3. 
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